Livedoid vasculitis - Livedoidni Vaskulitis
Livedoidni Vaskulitis (Livedoid vasculitis) je kronična kožna bolest koja se javlja pretežno kod žena mladih i srednjih godina. Jedan akronim koji se koristi za opisivanje njegovih karakteristika je "Bolni purpurni ulkusi sa retikularnim uzorkom donjih ekstremiteta" (PURPLE). Povezana je s nizom bolesti, uključujući kroničnu vensku hipertenziju i varikozitet.
☆ U rezultatima Stiftung Warentest-a za 2022. iz Njemačke, zadovoljstvo potrošača ModelDerm-om bilo je samo nešto niže nego s plaćenim telemedicinskim konsultacijama.
Može biti praćen bolom.
References
Livedoid vasculopathy je rijetko stanje kože koje karakteriziraju bolni čirevi koji se stalno vraćaju na potkolenice.
Livedoid vasculopathy (LV) is a rare thrombotic vasculopathy of the dermis characterized by painful, relapsing ulcers over the lower extremities. Diagnosis is challenging due to the overlap in clinical appearance and nomenclature with other skin disorders. Treatment selection is complicated by poor understanding of the pathogenesis of LV and lack of robust clinical trials evaluating therapy efficacy. The terminology and pathophysiology of LV are reviewed here, along with its epidemiology, clinical and histologic features, and treatment options. A diagnostic pathway is suggested to guide providers in evaluating for comorbidities, referring to appropriate specialists, and choosing from the available classes of therapy.
Livedoid vasculopathy (LV) is a rare thrombotic vasculopathy of the dermis characterized by painful, relapsing ulcers over the lower extremities. Diagnosis is challenging due to the overlap in clinical appearance and nomenclature with other skin disorders. Treatment selection is complicated by poor understanding of the pathogenesis of LV and lack of robust clinical trials evaluating therapy efficacy. The terminology and pathophysiology of LV are reviewed here, along with its epidemiology, clinical and histologic features, and treatment options. A diagnostic pathway is suggested to guide providers in evaluating for comorbidities, referring to appropriate specialists, and choosing from the available classes of therapy.
Livedoid vasculopathy je rijetko stanje kože koje uzrokuje ponavljajuće čireve na potkoljenicama, ostavljajući iza sebe blijede ožiljke poznate kao atrofija blanš. Iako je tačan uzrok još uvijek nejasan, vjeruje se da je povećano zgrušavanje krvi (hypercoagulability) glavni faktor, dok upala igra sporednu ulogu. Faktori koji doprinose zgrušavanju uključuju sljedeće - deficiencies in proteins C and S, genetic mutations like factor V Leiden, antithrombin III deficiency, prothrombin gene mutations, high levels of homocysteine. U biopsijama stanje pokazuje krvne ugruške unutar krvnih žila, zadebljanje zidova krvnih žila i ožiljke. Liječenje uključuje višestruki pristup koji se fokusira na prevenciju krvnih ugrušaka lijekovima kao što su lijekovi protiv trombocita, razrjeđivači krvi i fibrinolitička terapija. Za ovo stanje kože mogu se koristiti različiti lijekovi - colchicine and hydroxychloroquine, vasodilators, immunosuppressants.
Livedoid vasculopathy is a rare skin condition that causes recurring ulcers on the lower legs, leaving behind pale scars known as atrophie blanche. While the exact cause is still unclear, it's believed that increased blood clotting (hypercoagulability) is the main factor, with inflammation playing a secondary role. Factors contributing to clotting include as follows - deficiencies in proteins C and S, genetic mutations like factor V Leiden, antithrombin III deficiency, prothrombin gene mutations, high levels of homocysteine. In biopsies, the condition shows blood clots inside vessels, thickening of vessel walls, and scarring. Treatment involves a multi-pronged approach focusing on preventing blood clots with medications like anti-platelet drugs, blood thinners, and fibrinolytic therapy. Various drugs can be used for this skin condition - colchicine and hydroxychloroquine, vasodilators, immunosuppressants.
Livedoid vasculopathy is a rare skin condition that causes recurring ulcers on the lower legs, leaving behind pale scars known as atrophie blanche. While the exact cause is still unclear, it's believed that increased blood clotting (hypercoagulability) is the main factor, with inflammation playing a secondary role. Factors contributing to clotting include as follows - deficiencies in proteins C and S, genetic mutations like factor V Leiden, antithrombin III deficiency, prothrombin gene mutations, high levels of homocysteine. In biopsies, the condition shows blood clots inside vessels, thickening of vessel walls, and scarring. Treatment involves a multi-pronged approach focusing on preventing blood clots with medications like anti-platelet drugs, blood thinners, and fibrinolytic therapy. Various drugs can be used for this skin condition - colchicine and hydroxychloroquine, vasodilators, immunosuppressants.
Livedoid vasculopathy je rijetko stanje gdje se lezije javljaju na obje noge. Smatra se da je stvaranje krvnih ugrušaka u sićušnim krvnim žilama uzrokovano povećanim zgrušavanjem i smanjenim razgradnjom ugruška, zajedno s oštećenjem sluznice krvnih žila. Češći je kod žena, posebno između 15 i 50 godina. Prestanak pušenja, zbrinjavanje rana i korištenje lijekova kao što su razrjeđivači krvi i lijekovi protiv trombocita bili su efikasni.
Livedoid vasculopathy is a rare vasculopathy that is typically characterized by bilateral lower limb lesions. Increased thrombotic activity and decreased fibrinolytic activity along with endothelial damage are believed to be the cause of thrombus formation in the capillary vasculature. It is 3 times more common in females than in males, especially in patients between the ages of 15 to 50 years. There is no definite first-line treatment, but general measures like smoking cessation, wound care, and pharmacological measures like anticoagulants and antiplatelets have shown good results.
Livedoid vasculopathy is a rare vasculopathy that is typically characterized by bilateral lower limb lesions. Increased thrombotic activity and decreased fibrinolytic activity along with endothelial damage are believed to be the cause of thrombus formation in the capillary vasculature. It is 3 times more common in females than in males, especially in patients between the ages of 15 to 50 years. There is no definite first-line treatment, but general measures like smoking cessation, wound care, and pharmacological measures like anticoagulants and antiplatelets have shown good results.
